- Home
-
Learn, develop, connect
8th Global QA Conference
Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information -
Membership
Become part of RQA today
RQA membership is a great way to connect with your QA colleagues.
More information
RQA Community Hub
Join the community - networking, discussion and more. Open to all.
More information -
Knowledge Hub
Contribute to Quasar Magazine
Could you write an interesting article for the RQA community?
More information - About us
News Archive
MHRA - Unique opportunity for healthcare professionals to influence future MHRA safety communications and safety reporting systems
19th October 2022Unique opportunity for healthcare professionals to influence future MHRA safety communications and safety reporting systems
MHRA - annual accountability review minutes
19th October 2022The minutes of the ministerial annual accountability review of the Medicines and Healthcare products Regulatory Agency (MHRA).
MHRA - Quarterly Summary Reports added to Medical Device Guidance
29th September 2022Quarterly Summary Reports added to Medical Device Guidance
MHRA - Advertising and Promotion Section added to NIMAR
29th September 2022MHRA have added an 'Advertising and Promotion' Section added to NIMAR
MHRA - first new UK Approved Body to certify medical devices since Brexit appointed
29th September 2022MHRA appoints first new UK Approved Body to certify medical devices since Brexit
EC - Adoption of revised Annex VI to Regulation (EU) No 536/2014 (Clinical Trials Regulation, CTR)
28th September 2022The European Commission (EC) have adopted the revised Annex VI to Regulation (EU) No 536/2014 (Clinical Trials Regulation, CTR)
EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022
28th September 2022EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022
EMA - Veterinary Medicines Regulation Highlights.
28th September 2022The latest edition of the Veterinary Medicines Regulation Highlights.
EMA - biosimilar medicines approved in the European Union (EU) are interchangeable
28th September 2022EMA and the Heads of Medicines Agencies (HMA) have issued a joint statement confirming that biosimilar medicines approved in the European Union (EU) are interchangeable with their reference medicine or with an equivalent biosimilar.
FDA - Answers to GCP Questions
28th September 2022FDA have published an Excel sheet of answers to some GCP questions.
- Home
- Learn, develop, connect
- Membership
- Knowledge Hub
- About us